tirzepatide surpass 4 Lilly's achieves all primary and key secondary study outcomes against insulin glargine in adults with type 2 diabetes and increased cardiovascular risk in SURPASS-4 trial Tirzepatide versus Semaglutide Once Weekly

These symptoms can lead to dehydration and electrolyte disturbances, which may cause dizziness, weakness, and orthostatic symptoms

hdl:20.500.11820/0e890bda-4b1d-4786-a907-a03b1580fd07

Limited data exists for severe hepatic impairment, and both should be used with caution in this population

GIPR signaling in immune cells maintains metabolically beneficial type 2 immune responses in the white fat from obese mice

To the two familiar receptors (GLP-1 and GIP), it adds a third the glucagon receptor

Furthermore, blood glucose fluctuations may cause fatigue, particularly if you take insulin or sulfonylureas alongside your GLP-1 medication